Learn More
BACKGROUND AND OBJECTIVES The prothrombin G20210A mutation and factor V Leiden have been found to be associated with an increased risk of venous thrombosis, but the reported prevalences of the prothrombin gene variant both in the normal population and in patients with deep venous thrombosis (DVT) vary greatly in the literature. Moreover, the influence of(More)
  • A Vayá, M J Forner, +6 authors J Aznar
  • 2000
Thrombosis occurs in 20 to 30% of patients with Behçet's disease (BD), but the precise pathogenic mechanism underlying the thrombotic tendency in these patients is not well known. Venous thromboses are commonly located in the lower extremities, but right intracardiac thrombi are extremely rare. We report for the first time on a young patient with BD(More)
BACKGROUND Despite the existing evidence that highlights the benefits of oral anticoagulation therapy (OAT) self-testing and self-management by patients in comparison with conventional control, significant progress is still needed in the implementation of computer-based, Internet-assisted systems for OAT within health care centers. The telecontrol tool(More)
1 and some reports have assessed the genetic components of plasma variability in hemostasis-related phenotypes through family-based sampling designs. 1 The protein C (PC) anticoagulant pathway plays an important role in regulating thrombin generation and inflammatory reactions. PC circulates in plasma as a zymogen, which is activated on the surface of(More)
  • 1